Pfizer’s (PFE) 4Q adjusted EPS came in at $0.10 versus an estimated -$0.19 and revenue came in at $14.25B versus an estimated $14.36B. Lee Bohl and Sel Hardy discuss the takeaways from Pfizer’s earnings. They talk about how Pfizer can succeed in a post-pandemic world. Tune in to find out more about the stock market today.
Trading 360
30 Jan 2024
SHARE
Morning Trade Live
14 Feb 2024
Market On Close
21 Feb 2024
Morning Trade Live
09 Feb 2024
Morning Trade Live
05 Mar 2024
Morning Trade Live
29 Jan 2024
Morning Trade Live
29 Feb 2024